Tissue engineering is a relatively new field of basic and clinical science that is concerned, in part, with creating tissues that can augment or replace injured, defective, or diseased body parts. The approach to fabricating the tissues involves adding specific cell types to grow on a polymer scaffold having the shape of the tissue to be restored. The scaffold gradually disappears, while the cells continue developing in the scaffold shape. With the use of non-human animal cells, there has been considerable recent progress made in the engineering of skin, bladder, cartilage, and several other tissues.

The ribosome is the protein-producing nanomachine in cells that keeps the human body cranking along.

Researchers at Purdue University and The Catholic University of America have discovered the structure of an enzyme essential for the operation of "molecular motors" that package DNA into the head segment of some viruses during their assembly.

The enzyme, called an ATPase, provides energy to run the motor needed to insert DNA into the capsid, or head, of the T4 virus, which is called a bacteriophage because it infects bacteria. The same kind of motor, however, also is likely present in other viruses, including the human herpes virus.

Today, during the 85th General Session of the International Association for Dental Research, scientists are reporting that the use of saliva for clinical detection of major human diseases is only a few years away. Intense research is ongoing to discover diagnostic saliva biomarkers. A necessary prerequisite is to know, in a comprehensive manner, the informative biomarkers in saliva: the diagnostic alphabets. Like languages, which are synthesized from a foundation of alphabets, there are multiple diagnostic languages and thus diagnostic alphabets in saliva. The salivary proteome and the salivary transcriptome are two diagnostic alphabets that are ready for translational and clinical applications.

UCF's Conservatory Theatre and its partners are pushing the envelope of traditional theater by not only bringing it into the 21st Century, but launching it into the 22nd.

Using new techniques that merge the Internet 2 with traditional stage theatre, the University of Central Florida, Bradley University in Illinois and the University of Waterloo in Canada performed a play that put actors from Florida and Canada on the stage in Illinois without them ever leaving their respective campuses.

Geneticists have discovered a new gene that may put individuals at higher risk of developing cardiovascular disease.

The identification of the gene, called kalirin, implicates a biological mechanism never before linked to cardiovascular disease, according to the Duke researchers who led the study. Further study of this new clue could lead to novel ways to treat or even prevent the disease, the researchers said.

"The ultimate goal is to determine who will develop cardiovascular disease," said lead study investigator Liyong Wang, Ph.D., a research associate at the Duke Center for Human Genetics. "Our discovery could lead to a clinical tool for assessing a person's risk of coronary artery disease, so that physicians can try to prevent the disease from progressing."